CompletedPHASE2, PHASE3NCT02950883
Saline Hypertonic in Preschoolers + CT
Studying Cystic fibrosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Washington, the Collaborative Health Studies Coordinating Center
- Principal Investigator
- Harm Tiddens, MD, PhDErasmus Medical Centre, Rotterdam
- Intervention
- Active Treatment Group 7% Hypertonic Saline(drug)
- Enrollment
- 116 enrolled
- Eligibility
- 3-5 years · All sexes
- Timeline
- 2015 – 2021
Study locations (25)
- Children's Hospital of Colorado, Aurora, Colorado, United States
- Riley Hospital for Children, Indianapolis, Indiana, United States
- Washington University School of Medicine, St Louis, Missouri, United States
- University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
- Oregon Health Sciences University, Portland, Oregon, United States
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States
- Seattle Children's Hospital, Seattle, Washington, United States
- Royal Women's and Children Hospital, Adelaide, Australia
- Lady Cilento Children's Hospital, Brisbane, Australia
- Royal Children's Hospital, Melbourne, Australia
- John Hunter Children's Hospital, Newcastle, Australia
- Children's Hospital at Westmead, Sydney, Australia
- Sydney Children's Hospital at Randwick, Sydney, Australia
- Perth Children's Hospital, West Perth, Australia
- Universitair Ziekenhuis Children's Hospital, Brussels, Belgium
- +10 more locations on ClinicalTrials.gov
Collaborators
Cystic Fibrosis Foundation
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02950883 on ClinicalTrials.govOther trials for Cystic fibrosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT04530383Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel FunctionUniversity of Kansas Medical Center
- RECRUITINGPHASE2NCT07450547Phase 2 Study to Assess the Safety and Efficacy of ANG003Anagram Therapeutics, Inc.
- RECRUITINGPHASE1NCT07437105Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-272 in Healthy ParticipantsVertex Pharmaceuticals Incorporated
- RECRUITINGNANCT07436351ACT With CF Self-Help ToolkitThomas Jefferson University
- RECRUITINGNANCT07314229Prevalence of Exercise-induced Ventilatory Limitation and Associated Factors in Patients With Cystic Fibrosis Receiving Elexacaftor-Tezacaftor-IvacaftorUniversity Hospital, Lille
- RECRUITINGNCT07083557Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)Bettina Mittendorfer
- RECRUITINGNCT07369414Environmental Reservoirs of Non-tuberculous Mycobacteria in Cystic Fibrosis Households: A Case-control Study of Exposure Risk at HomeResearch Center Borstel
- RECRUITINGNCT07505797ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE)iSono Health, Inc.